{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:30:10Z","timestamp":1784136610720,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003977"],"award-info":[{"award-number":["82003977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703772"],"award-info":[{"award-number":["81703772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803819"],"award-info":[{"award-number":["81803819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873036"],"award-info":[{"award-number":["81873036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Huadong MedicineJoint Funds of the Zhejiang Provincial Science Foundation of China","award":["LHDMZ22H280002"],"award-info":[{"award-number":["LHDMZ22H280002"]}]},{"name":"the Key Research and Development Program of Zhejiang Province","award":["2020C04020"],"award-info":[{"award-number":["2020C04020"]}]},{"name":"the Key Laboratory of pharmacology research on hypertension and related diseases treated by traditional Chinese medicine in Zhejiang Province","award":["2012E10002"],"award-info":[{"award-number":["2012E10002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic hypertension (MH) has become the most common type of hypertension in recent years due to unhealthy eating habits and lifestyles of people, such as over-eating alcohol, high fat, and sugar diets (ACHFSDs). Therefore, effective means to combat MH are needed. Previous studies have shown that <jats:italic>Panax notoginseng<\/jats:italic> (Burkill) F. H. Chen flower saponins (PNFS) can lower blood pressure in spontaneously hypertensive rats (SHR). However, whether it acts on MH and its mechanism of action remain unclear.\u00a0<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The pharmacodynamic effects of PNFS were evaluated in rats with ACHFSDs-induced MH. The blood pressure, blood biochemical, grip strength, face temperature, vertigo time, and liver index were estimated. The histological changes in the liver and aorta were observed using hematoxylin and eosin staining. The levels of ET-1, TXB<jats:sub>2<\/jats:sub>, NO, PGI<jats:sub>2<\/jats:sub>, Renin, ACE, Ang II, and ALD in plasma were detected using ELISA. The levels of C3, KLF5, LXR\u03b1, and Renin in kidney tissues were measured using qRT-PCR.The expression levels of C3, KLF5, LXR\u03b1, and Renin in kidney tissues were examined using Western blotting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the present study, PNFS was found to reduce blood pressure, face temperature, and vertigo time, increase grip strength and improve dyslipidemia in rats with MH. In addition, PNFS decreased the plasma levels of ET-1 and TXB<jats:sub>2<\/jats:sub>, elevated the levels of NO and PGI<jats:sub>2<\/jats:sub>, and improved pathological aortic injury. Meanwhile, PNFS decreased the plasma levels of Renin, ACE, Ang II, and ALD. QRT-PCR and Western bolt showed that PNFS downregulated C3, KLF5, LXR\u03b1, and Renin protein and mRNA expression in the kidneys of rats with MH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The finding of the present study suggested that PNFS could downregulate C3 and KLF-5 expression in rats with MH, thereby inhibiting the overactivation of the renin\u2013angiotensin\u2013aldosterone system, while improving vascular endothelial function and ultimately reducing blood pressure in rats with MH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03828-2","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T07:02:59Z","timestamp":1674025379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Beneficial effects of Panax notoginseng (Burkill) F. H. Chen flower saponins in rats with metabolic hypertension by inhibiting the activation of the renin\u2013angiotensin\u2013aldosterone system through complement 3"],"prefix":"10.1186","volume":"23","author":[{"given":"Qiqi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqiu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"issue":"10112","key":"3828_CR1","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE million persons project). The Lancet. 2017;390(10112):2549\u201358.","journal-title":"The Lancet"},{"issue":"22","key":"3828_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China. Circulation. 2018;137(22):2344\u201356.","journal-title":"Circulation"},{"issue":"8","key":"3828_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tcm.2017.06.002","volume":"27","author":"J Rehm","year":"2017","unstructured":"Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends Cardiovasc Med. 2017;27(8):534\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"3828_CR4","doi-asserted-by":"publisher","first-page":"755140","DOI":"10.3389\/fphar.2021.755140","volume":"12","author":"YJ Wang","year":"2021","unstructured":"Wang YJ, Su J, Yu JJ, Yan MQ, Shi ML, Huang QD, et al. Buddleoside-Rich Chrysanthemum indicum L. Extract has a beneficial effect on metabolic hypertensive rats by inhibiting the enteric-origin LPS\/TLR4 pathway. Front Pharmacol. 2021;12:755140.","journal-title":"Front Pharmacol"},{"issue":"12","key":"3828_CR5","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1039\/D0FO02890H","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, He X, Jin HY, Wang HY, Zhou FC, Zhang NY, et al. Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43\/41 pathway. Food Funct. 2021;12(12):5524\u201338.","journal-title":"Food Funct"},{"issue":"5","key":"3828_CR6","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1159\/000443107","volume":"38","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Xiong S, Liu D. The gastrointestinal tract: an initial organ of metabolic hypertension? Cell Physiol Biochem. 2016;38(5):1681\u201394.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"3828_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0033-0620(93)90020-E","volume":"36","author":"PE Pool","year":"1993","unstructured":"Pool PE. The case for metabolic hypertension: is it time to restructure the hypertension paradigm? Prog Cardiovasc Dis. 1993;36(1):1\u201338.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"3828_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11684-013-0264-4","volume":"7","author":"Z Zhu","year":"2013","unstructured":"Zhu Z, Wang P, Ma S. Metabolic hypertension: concept and practice. Front Med. 2013;7(2):201\u20136.","journal-title":"Front Med"},{"issue":"6","key":"3828_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/eci.12275","volume":"44","author":"B Nilsson","year":"2014","unstructured":"Nilsson B, Hamad OA, Ahlstr\u00f6m H, Kullberg J, Johansson L, Lindhagen L, et al. C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. Eur J Clin Invest. 2014;44(6):587\u201396.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"3828_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molimm.2014.06.031","volume":"61","author":"E Hertle","year":"2014","unstructured":"Hertle E, Stehouwer CD, van Greevenbroek MM. The complement system in human cardiometabolic disease. Mol Immunol. 2014;61(2):135\u201348.","journal-title":"Mol Immunol"},{"issue":"1","key":"3828_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","volume":"34","author":"K Oikonomopoulou","year":"2012","unstructured":"Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between coagulation and complement\u2013their role in inflammation. Semin Immunopathol. 2012;34(1):151\u201365.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3828_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1574887112666171128134552","volume":"13","author":"F Ursini","year":"2018","unstructured":"Ursini F, Abenavoli L. The emerging role of complement C3 as a biomarker of insulin resistance and Cardiometabolic Diseases: preclinical and clinical evidence. Rev Recent Clin Trials. 2018;13(1):61\u20138.","journal-title":"Rev Recent Clin Trials"},{"issue":"3\u20134","key":"3828_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF01988727","volume":"34","author":"WA Schumacher","year":"1991","unstructured":"Schumacher WA, Fantone JC, Kunkel SE, Webb RC, Lucchesi BR. The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions. 1991;34(3\u20134):345\u20139.","journal-title":"Agents Actions"},{"issue":"4","key":"3828_CR14","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4049\/jimmunol.169.4.2102","volume":"169","author":"IU Schraufstatter","year":"2002","unstructured":"Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol. 2002;169(4):2102\u201310.","journal-title":"J Immunol"},{"issue":"3","key":"3828_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12020-018-1712-3","volume":"62","author":"Y Xin","year":"2018","unstructured":"Xin Y, Hertle E, van der Kallen CJH, Schalkwijk CG, Stehouwer CDA, van Greevenbroek MMJ. Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study. Endocrine. 2018;62(3):617\u201327.","journal-title":"Endocrine"},{"issue":"4","key":"3828_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.jhh.1002129","volume":"21","author":"G Engstr\u00f6m","year":"2007","unstructured":"Engstr\u00f6m G, Hedblad B, Berglund G, Janzon L, Lindg\u00e4rde F. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens. 2007;21(4):276\u201382.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"3828_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/10641963.2016.1210622","volume":"39","author":"X Bao","year":"2017","unstructured":"Bao X, Meng G, Zhang Q, Liu L, Wu H, Du H, et al. Elevated serum complement C3 levels are associated with prehypertension in an adult population. Clin Exp Hypertens. 2017;39(1):42\u20139.","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"3828_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/01.hjr.0000244582.30421.b2","volume":"14","author":"G Engstr\u00f6m","year":"2007","unstructured":"Engstr\u00f6m G, Hedblad B, Janzon L, Lindg\u00e4rde F. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil. 2007;14(3):392\u20137.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"12","key":"3828_CR19","doi-asserted-by":"publisher","first-page":"e28578","DOI":"10.1371\/journal.pone.0028578","volume":"6","author":"EM Bauer","year":"2011","unstructured":"Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM. Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS ONE. 2011;6(12):e28578.","journal-title":"PLoS ONE"},{"issue":"2","key":"3828_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbrc.2007.12.160","volume":"367","author":"EH Yao","year":"2008","unstructured":"Yao EH, Fukuda N, Ueno T, Tsunemi A, Endo M, Matsumoto K. Complement 3 activates the KLF5 gene in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2008;367(2):468\u201373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"3828_CR21","doi-asserted-by":"publisher","first-page":"F957","DOI":"10.1152\/ajprenal.00344.2013","volume":"305","author":"X Zhou","year":"2013","unstructured":"Zhou X, Fukuda N, Matsuda H, Endo M, Wang X, Saito K, et al. Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice. Am J Physiol Renal Physiol. 2013;305(7):F957\u201367.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"3828_CR22","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1172\/JCI24594","volume":"115","author":"F Morello","year":"2005","unstructured":"Morello F, Boer R, Steffensen KR, Gnecchi M, Dzau VJ. Liver X receptors \u03b1 and \u03b2 regulate renin expression in vivo. J Clin Invest. 2005;115(7):1913.","journal-title":"J Clin Invest"},{"key":"3828_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317\u201325.","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"3828_CR24","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"P Hao","year":"2017","unstructured":"Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese Medicine for Cardiovascular Disease. J Am Coll Cardiol. 2017;69(24):2952\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"3828_CR25","doi-asserted-by":"publisher","first-page":"105263","DOI":"10.1016\/j.phrs.2020.105263","volume":"161","author":"H Liu","year":"2020","unstructured":"Liu H, Lu X, Hu Y, Fan X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol Res. 2020;161:105263.","journal-title":"Pharmacol Res"},{"key":"3828_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fphar.2017.00702","volume":"8","author":"L Duan","year":"2017","unstructured":"Duan L, Xiong X, Hu J, Liu Y, Li J, Wang J. Panax notoginseng saponins for treating coronary artery disease: a functional and mechanistic overview. Front Pharmacol. 2017;8:702.","journal-title":"Front Pharmacol"},{"issue":"11","key":"3828_CR27","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.3390\/molecules23112781","volume":"23","author":"S Hu","year":"2018","unstructured":"Hu S, Wu Y, Zhao B, Hu H, Zhu B, Sun Z, et al. Panax notoginseng saponins protect cerebral microvascular endothelial cells against oxygen-glucose Deprivation\/Reperfusion-Induced Barrier Dysfunction via activation of PI3K\/Akt\/Nrf2 antioxidant signaling pathway. Molecules. 2018;23(11):2781.","journal-title":"Molecules"},{"key":"3828_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jep.2019.02.035","volume":"236","author":"C Xu","year":"2019","unstructured":"Xu C, Wang W, Wang B, Zhang T, Cui X, Pu Y, et al. Analytical methods and biological activities of Panax notoginseng saponins: recent trends. J Ethnopharmacol. 2019;236:443\u201365.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"3828_CR29","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3390\/molecules17055836","volume":"17","author":"JB Wan","year":"2012","unstructured":"Wan JB, Zhang QW, Hong SJ, Li P, Li SP, Wang YT. Chemical investigation of saponins in different parts of Panax notoginseng by pressurized liquid extraction and liquid chromatography-electrospray ionization-tandem mass spectrometry. Molecules. 2012;17(5):5836\u201353.","journal-title":"Molecules"},{"issue":"36","key":"3828_CR30","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1021\/jf502214x","volume":"62","author":"JR Wang","year":"2014","unstructured":"Wang JR, Yau LF, Gao WN, Liu Y, Yick PW, Liu L, et al. Quantitative comparison and metabolite profiling of saponins in different parts of the root of Panax notoginseng. J Agric Food Chem. 2014;62(36):9024\u201334.","journal-title":"J Agric Food Chem"},{"issue":"11","key":"3828_CR31","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ptr.6167","volume":"32","author":"S Zhang","year":"2018","unstructured":"Zhang S, Chen C, Lu W, Wei L. Phytochemistry, pharmacology, and clinical use of Panax notoginseng flowers buds. Phytother Res. 2018;32(11):2155\u201363.","journal-title":"Phytother Res"},{"issue":"6","key":"3828_CR32","first-page":"1443","volume":"5","author":"Y Wang","year":"2012","unstructured":"Wang Y, Qian P, Liu P, Wei L, Cao M, Zhou L, et al. Effects of Panax notoginseng flower extract on the TGF-\u03b2\/Smad signal transduction pathway in heart remodeling of human chymase transgenic mice. Mol Med Rep. 2012;5(6):1443\u20138.","journal-title":"Mol Med Rep"},{"key":"3828_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jep.2016.01.022","volume":"181","author":"BR Yang","year":"2016","unstructured":"Yang BR, Cheung KK, Zhou X, Xie RF, Cheng PP, Wu S, et al. Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosis. J Ethnopharmacol. 2016;181:50\u20138.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"3828_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1021\/np030015l","volume":"66","author":"M Yoshikawa","year":"2003","unstructured":"Yoshikawa M, Morikawa T, Kashima Y, Ninomiya K, Matsuda H. Structures of new dammarane-type Triterpene Saponins from the flower buds of Panax notoginseng and hepatoprotective effects of principal Ginseng Saponins. J Nat Prod. 2003;66(7):922\u20137.","journal-title":"J Nat Prod"},{"issue":"2","key":"3828_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ptr.3587","volume":"26","author":"Y Zeng","year":"2012","unstructured":"Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: a review of current mechanism studies. Phytother Res. 2012;26(2):159\u201367.","journal-title":"Phytother Res"},{"issue":"2","key":"3828_CR36","first-page":"367","volume":"32","author":"C Min","year":"2014","unstructured":"Min C, Danfei L, Guoyin W, Youhua W, Duan Z, Li Z, et al. Research of Panax Notoginseng Flower Saponins\u2019 Antihypertensive Effect on spontaneous hypertension rats. Zhong Hua Zhong Yi Yao Xue Kan. 2014;32(2):367\u20139.","journal-title":"Zhong Hua Zhong Yi Yao Xue Kan"},{"issue":"7","key":"3828_CR37","first-page":"1314","volume":"27","author":"C Min","year":"2012","unstructured":"Min C, Youhua W, Fubo W, Duan Z, Li Z, Yiqiang L, et al. Effect study on blood pressure by Panax Notoginseng Flower Saponins. Guang Ming Zhong Yi. 2012;27(7):1314\u20135.","journal-title":"Guang Ming Zhong Yi"},{"issue":"9","key":"3828_CR38","first-page":"1418","volume":"31","author":"W Li","year":"2008","unstructured":"Li W, Hao Z. Studies on separation and purification of total saponin from flower buds of Panax notoginseng by macroporous resins. Zhong Yao Cai. 2008;31(9):1418\u201321.","journal-title":"Zhong Yao Cai"},{"key":"3828_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","volume":"100","author":"MA Incalza","year":"2018","unstructured":"Incalza MA, D\u2019Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1\u201319.","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"3828_CR40","first-page":"690","volume":"40","author":"X Liang","year":"2020","unstructured":"Liang X, Wang Q, Jiang Z, Li Z, Zhang M, Yang P, et al. Clinical research linking traditional Chinese Medicine constitution types with diseases: a literature review of 1639 observational studies. J Tradit Chin Med. 2020;40(4):690\u2013702.","journal-title":"J Tradit Chin Med"},{"issue":"9","key":"3828_CR41","first-page":"15","volume":"90","author":"VA Parfenov","year":"2018","unstructured":"Parfenov VA, Ostroumova \u0422\u041c, Ostroumova OD, Pavleyva EE. Features of the clinical picture in patients of middle age with essential hypertension. Ter Arkh. 2018;90(9):15\u201326.","journal-title":"Ter Arkh"},{"issue":"12","key":"3828_CR42","doi-asserted-by":"publisher","first-page":"e024406","DOI":"10.1136\/bmjopen-2018-024406","volume":"8","author":"DL Vetrano","year":"2018","unstructured":"Vetrano DL, Palmer KM, Galluzzo L, Giampaoli S, Marengoni A, Bernabei R, et al. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open. 2018;8(12):e024406.","journal-title":"BMJ Open"},{"issue":"1","key":"3828_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/13880209.2020.1831026","volume":"58","author":"RX Wang","year":"2020","unstructured":"Wang RX, He RL, Jiao HX, Zhang RT, Guo JY, Liu XR, et al. Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition. Pharm Biol. 2020;58(1):1055\u201363.","journal-title":"Pharm Biol"},{"key":"3828_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6882-12-53","volume":"12","author":"H Chen","year":"2012","unstructured":"Chen H, Yin J, Deng Y, Yang M, Xu L, Teng F, et al. The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats. BMC Complement Altern Med. 2012;12:53.","journal-title":"BMC Complement Altern Med"},{"issue":"13","key":"3828_CR45","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1111\/bph.12660","volume":"171","author":"Y Wang","year":"2014","unstructured":"Wang Y, Dong J, Liu P, Lau CW, Gao Z, Zhou D,et al. Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats. Br J Pharmacol. 2014;171(13):3171\u201381.","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"3828_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejphar.2009.01.033","volume":"606","author":"BX Cai","year":"2009","unstructured":"Cai BX, Li XY, Chen JH, Tang YB, Wang GL, Zhou JG, et al. Ginsenoside-Rd, a new voltage-independent Ca2 + entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats. Eur J Pharmacol. 2009;606(1\u20133):142\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"3828_CR47","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1111\/1750-3841.15505","volume":"85","author":"Y Xue","year":"2020","unstructured":"Xue Y, Fu W, Liu Y, Yu P, Sun M, Li X, et al. Ginsenoside Rb2 alleviates myocardial ischemia\/reperfusion injury in rats through SIRT1 activation. J Food Sci. 2020;85(11):4039\u201349.","journal-title":"J Food Sci"},{"issue":"7","key":"3828_CR48","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1111\/1750-3841.15757","volume":"86","author":"Y Xue","year":"2021","unstructured":"Xue Y, Yu X, Zhang X, Yu P, Li Y, Fu W, et al. Protective effects of ginsenoside rc against acute cold exposure-induced myocardial injury in rats. J Food Sci. 2021;86(7):3252\u201364.","journal-title":"J Food Sci"},{"issue":"9","key":"3828_CR49","first-page":"740","volume":"32","author":"L Changlei","year":"2018","unstructured":"Changlei L, Huiling Y, Xiaoqing C. Regulation of Panax Notoginseng Flower Saponins on lipids in hyperlipidemia model rats. Chin J Pharmacol Toxicol. 2018;32(9):740.","journal-title":"Chin J Pharmacol Toxicol"},{"issue":"4","key":"3828_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41440-019-0371-y","volume":"43","author":"L Chen","year":"2020","unstructured":"Chen L, Fukuda N, Matsumoto T, Abe M. Role of complement 3 in the pathogenesis of hypertension. Hypertens Res. 2020;43(4):255\u201362.","journal-title":"Hypertens Res"},{"issue":"10","key":"3828_CR51","doi-asserted-by":"publisher","first-page":"e012327","DOI":"10.1161\/JAHA.119.012327","volume":"8","author":"L Chen","year":"2019","unstructured":"Chen L, Fukuda N, Otsuki T, Tanaka S, Nakamura Y, Kobayashi H, et al. Increased complement 3 with suppression of miR-145 induces the synthetic phenotype in vascular smooth muscle cells from spontaneously hypertensive rats. J Am Heart Assoc. 2019;8(10):e012327.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"3828_CR52","doi-asserted-by":"publisher","first-page":"F1747","DOI":"10.1152\/ajprenal.00370.2018","volume":"315","author":"E Negishi","year":"2018","unstructured":"Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, et al. Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2018;315(6):F1747\u201358.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"3828_CR53","first-page":"1851","volume":"33","author":"G Ying","year":"2011","unstructured":"Ying G, Su D, Jie Z, Shisen F, Zheng W. Effects of total panax notoginseng saponins on neurological function and complement 3 in patients with acute intracerebral hemorrhage. Chin Traditional Patent Med. 2011;33(11):1851\u20133.","journal-title":"Chin Traditional Patent Med"},{"issue":"6","key":"3828_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11906-010-0150-2","volume":"12","author":"K Dharmashankar","year":"2010","unstructured":"Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12(6):448\u201355.","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"3828_CR55","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1139\/cjpp-2016-0615","volume":"95","author":"SPB Caligiuri","year":"2017","unstructured":"Caligiuri SPB, Aukema HM, Ravandi A, Lavall\u00e9e R, Guzman R, Pierce GN. Specific plasma oxylipins increase the odds of cardiovascular and cerebrovascular events in patients with peripheral artery disease. Can J Physiol Pharmacol. 2017;95(8):961\u20138.","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"3828_CR56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000477572","volume":"42","author":"M Xu","year":"2017","unstructured":"Xu M, Lu YP, Hasan AA, Hocher B. Plasma. ET-1 concentrations are elevated in patients with hypertension - Meta - analysis of Clinical Studies. Kidney Blood Press Res. 2017;42(2):304\u201313.","journal-title":"Kidney Blood Press Res"}],"updated-by":[{"DOI":"10.1186\/s12906-023-03893-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000}}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03828-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03828-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03828-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T09:05:47Z","timestamp":1678266347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03828-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3828"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03828-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12906-023-03893-1","asserted-by":"object"}]},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12906-023-03893-1","URL":"https:\/\/doi.org\/10.1186\/s12906-023-03893-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The plant handing procedures in this study comply with local and national regulations. The animal procedures were approved by the Zhejiang Chinese Medical University of Science Animal Care and Welfare Committee (permit number: ZSLL-2017-185). The ARRIVE guidelines were adhered to throughout this study. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}